Table 4.
Effect of syndecan-1 levels two hours after surgery on morbidity and mortality within the first 30 days
| Frequency | B (SE) | CI 95% B | p-value | |
|---|---|---|---|---|
| Renal failure | 15 (14%) | 308.29 (1251.15) | -2172.51–2789.09 | 0.806 |
| Pulmonary complications | 11 (10.3%) | -1673.92 (1421.32) | -4492.14–1144.30 | 0.242 |
| Need for ventilatory support | 6 (5.6%) | -1482.32 (1883.04) | -5216.04–2251.41 | 0.433 |
| Cardiovascular events | 2 (1.9%) | -1925.18 (3202.72) | -8275.58–4425.22 | 0.549 |
| Need for reoperation | 9 (8.4%) | -345.11 (1565.09) | -3448.40–2758.17 | 0.826 |
| Surgical wound infection | 16 (15%) | -982.78 (1214.63) | -3391.17–1425.61 | 0.420 |
| ICU length of stay ** | 1.49 +/- 2.24 | -125.64 (194.71) | -511.72–260.43 | 0.520 |
| Length of hospital stay (days) ** | 7.73 +/- 6.65 | -62.93 (65.39) | -192.58–66.73 | 0.338 |
| Readmission to ICU | 2 (1.9%) | -721.18 (3207.45) | -7080.96–5638.61 | 0.823 |
| Mortality | 1 (0.9%) | -694.33 (2631.19) | -2.288,72–1306.83 | 0.589 |
Values with ± are expressed as mean ± standard deviation
SE Standard error, CI Confidence interval
Bunstandardized regression coefficient
**Expressed with mean and standard deviation